Iridex (IRIX) Liabilities from Discontinued Operations (2011 - 2012)
Iridex's quarterly Liabilities from Discontinued Operations came in at 67000.0 in Q3 2012, down 15.19% quarter-over-quarter from 79000.0 in Q2 2012.
Iridex has reported Liabilities from Discontinued Operations for 2 years, with the latest figure at 67000.0 in Q3 2012.
- For the quarter ending Q3 2012, Liabilities from Discontinued Operations changed N/A year-over-year to 67000.0; the trailing twelve-month figure through Sep 2012 stood at 67000.0 (changed N/A YoY), and the FY2011 full-year result was 2663000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q3 2012 stood at 67000.0, down from 79000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 2663000.0 in Q4 2011, with the low at 67000.0 in Q3 2012.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Iridex | 18.87 Mn | 14.27 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 29, 2012 | 67,000.00 |
| Sep 29, 2012 | 67,000.00 |
| Jun 30, 2012 | 79,000.00 |
| Jun 30, 2012 | 79,000.00 |
| Mar 31, 2012 | 259,000.00 |
| Mar 31, 2012 | 259,000.00 |
| Dec 31, 2011 | 2.66 Mn |
| Dec 31, 2011 | 2.66 Mn |